DAIICHI SANKYO COMPANY, LIMITED · Tokyo Japan
| 3-5-1 Nihombashi-Honcho, Chuo-Ku | Phone: +81-3-6255-1126 |
| Tokyo | Fax: +81-3-6255-1132 |
| 103-8426 | |
| Japan | 
Map This Company |
DAIICHI SANKYO COMPANY, LIMITED Rankings
| Nikkei 225 |
Company Description
Daiichi Sankyo is a leader in the Japanese pharmaceuticals business. The company manufactures prescription drugs, including treatments for cardiovascular, bone and joint, autoimmune, metabolic, and infectious diseases. Top products include Olmetec for hypertension and Loxonin for inflammation. Daiichi Sankyo also makes over-the-counter (OTC) and generic drugs through subsidiaries including Daiichi Sankyo Healthcare and majority owned
DAIICHI SANKYO COMPANY, LIMITED Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | PublicHeadquarters |
|---|---|
| Fiscal Year-End | March |
| 2011 Employees | 30,488 |
Executives
34 executives listed for DAIICHI SANKYO COMPANY, LIMITED's Tokyo, Japan location.
| Chairman | Takashi Shoda | |
|---|---|---|
| President, CEO, and Director | Joji Nakayama | |
| Executive Officer and Global Corporate Finance Officer | Manabu Sakai |